nodes	percent_of_prediction	percent_of_DWPC	metapath
Bupivacaine—Wound discharge increased—Capecitabine—esophageal cancer	0.0404	0.0614	CcSEcCtD
Bupivacaine—Apprehension—Cisplatin—esophageal cancer	0.0206	0.0313	CcSEcCtD
Bupivacaine—Wound secretion—Capecitabine—esophageal cancer	0.02	0.0305	CcSEcCtD
Bupivacaine—CNS toxicity—Methotrexate—esophageal cancer	0.0188	0.0286	CcSEcCtD
Bupivacaine—Cranial nerve paralysis—Methotrexate—esophageal cancer	0.0188	0.0286	CcSEcCtD
Bupivacaine—Paraplegia—Methotrexate—esophageal cancer	0.016	0.0243	CcSEcCtD
Bupivacaine—Extravasation—Carboplatin—esophageal cancer	0.0154	0.0234	CcSEcCtD
Bupivacaine—Diplegia—Methotrexate—esophageal cancer	0.0149	0.0227	CcSEcCtD
Bupivacaine—Monoplegia—Methotrexate—esophageal cancer	0.014	0.0213	CcSEcCtD
Bupivacaine—Neurological symptom—Cisplatin—esophageal cancer	0.0131	0.0199	CcSEcCtD
Bupivacaine—Meningism—Methotrexate—esophageal cancer	0.0125	0.019	CcSEcCtD
Bupivacaine—Arachnoiditis—Methotrexate—esophageal cancer	0.0118	0.018	CcSEcCtD
Bupivacaine—Hypoaesthesia oral—Capecitabine—esophageal cancer	0.0111	0.0169	CcSEcCtD
Bupivacaine—Neurotoxicity—Cisplatin—esophageal cancer	0.0102	0.0155	CcSEcCtD
Bupivacaine—Sensory disturbance—Capecitabine—esophageal cancer	0.00937	0.0143	CcSEcCtD
Bupivacaine—Meningitis aseptic—Methotrexate—esophageal cancer	0.00918	0.014	CcSEcCtD
Bupivacaine—Slurred speech—Cisplatin—esophageal cancer	0.00882	0.0134	CcSEcCtD
Bupivacaine—Shivering—Capecitabine—esophageal cancer	0.0078	0.0119	CcSEcCtD
Bupivacaine—Neurotoxicity—Capecitabine—esophageal cancer	0.0075	0.0114	CcSEcCtD
Bupivacaine—Drug hypersensitivity—Capecitabine—esophageal cancer	0.00722	0.011	CcSEcCtD
Bupivacaine—Dysaesthesia—Capecitabine—esophageal cancer	0.00672	0.0102	CcSEcCtD
Bupivacaine—Depressed mood—Capecitabine—esophageal cancer	0.0065	0.00989	CcSEcCtD
Bupivacaine—Prurigo—Capecitabine—esophageal cancer	0.00629	0.00958	CcSEcCtD
Bupivacaine—Paraesthesia oral—Capecitabine—esophageal cancer	0.0062	0.00943	CcSEcCtD
Bupivacaine—Swelling face—Capecitabine—esophageal cancer	0.0061	0.00929	CcSEcCtD
Bupivacaine—Paresis—Methotrexate—esophageal cancer	0.00593	0.00902	CcSEcCtD
Bupivacaine—Neurotoxicity—Methotrexate—esophageal cancer	0.00558	0.00849	CcSEcCtD
Bupivacaine—Sneezing—Capecitabine—esophageal cancer	0.00525	0.00799	CcSEcCtD
Bupivacaine—Lidocaine—EGFR—esophageal cancer	0.00483	0.472	CrCbGaD
Bupivacaine—Infection—Carboplatin—esophageal cancer	0.00476	0.00725	CcSEcCtD
Bupivacaine—Neck stiffness—Methotrexate—esophageal cancer	0.00454	0.00691	CcSEcCtD
Bupivacaine—Extravasation—Cisplatin—esophageal cancer	0.00452	0.00688	CcSEcCtD
Bupivacaine—Nuchal rigidity—Methotrexate—esophageal cancer	0.00417	0.00635	CcSEcCtD
Bupivacaine—Dysarthria—Cisplatin—esophageal cancer	0.00417	0.00634	CcSEcCtD
Bupivacaine—Ileus—Capecitabine—esophageal cancer	0.00411	0.00625	CcSEcCtD
Bupivacaine—Pain—Carboplatin—esophageal cancer	0.0041	0.00624	CcSEcCtD
Bupivacaine—Lidocaine—CYP2A6—esophageal cancer	0.00395	0.385	CrCbGaD
Bupivacaine—Hyperkalaemia—Cisplatin—esophageal cancer	0.00387	0.00589	CcSEcCtD
Bupivacaine—Ventricular fibrillation—Capecitabine—esophageal cancer	0.0038	0.00577	CcSEcCtD
Bupivacaine—Body temperature increased—Carboplatin—esophageal cancer	0.00379	0.00577	CcSEcCtD
Bupivacaine—Fungal infection—Capecitabine—esophageal cancer	0.00376	0.00573	CcSEcCtD
Bupivacaine—Neuropathy—Cisplatin—esophageal cancer	0.0037	0.00563	CcSEcCtD
Bupivacaine—Rigors—Capecitabine—esophageal cancer	0.00356	0.00542	CcSEcCtD
Bupivacaine—Extrasystoles—Capecitabine—esophageal cancer	0.00345	0.00525	CcSEcCtD
Bupivacaine—Musculoskeletal stiffness—Capecitabine—esophageal cancer	0.00324	0.00493	CcSEcCtD
Bupivacaine—Skin discolouration—Capecitabine—esophageal cancer	0.00322	0.0049	CcSEcCtD
Bupivacaine—Ventricular extrasystoles—Capecitabine—esophageal cancer	0.00322	0.0049	CcSEcCtD
Bupivacaine—Hypocalcaemia—Capecitabine—esophageal cancer	0.00317	0.00483	CcSEcCtD
Bupivacaine—Paralysis—Methotrexate—esophageal cancer	0.00311	0.00474	CcSEcCtD
Bupivacaine—Blood bilirubin increased—Capecitabine—esophageal cancer	0.00307	0.00467	CcSEcCtD
Bupivacaine—Dysarthria—Capecitabine—esophageal cancer	0.00307	0.00467	CcSEcCtD
Bupivacaine—Anaphylactoid reaction—Cisplatin—esophageal cancer	0.00296	0.0045	CcSEcCtD
Bupivacaine—Neck pain—Capecitabine—esophageal cancer	0.00294	0.00448	CcSEcCtD
Bupivacaine—Blood pressure increased—Capecitabine—esophageal cancer	0.00291	0.00442	CcSEcCtD
Bupivacaine—Urinary incontinence—Capecitabine—esophageal cancer	0.00281	0.00427	CcSEcCtD
Bupivacaine—Depressed level of consciousness—Capecitabine—esophageal cancer	0.00281	0.00427	CcSEcCtD
Bupivacaine—Fungal infection—Methotrexate—esophageal cancer	0.0028	0.00426	CcSEcCtD
Bupivacaine—Neuropathy—Capecitabine—esophageal cancer	0.00273	0.00415	CcSEcCtD
Bupivacaine—Blood creatinine increased—Cisplatin—esophageal cancer	0.00268	0.00408	CcSEcCtD
Bupivacaine—Orthostatic hypotension—Cisplatin—esophageal cancer	0.00261	0.00398	CcSEcCtD
Bupivacaine—Aspartate aminotransferase increased—Cisplatin—esophageal cancer	0.00258	0.00392	CcSEcCtD
Bupivacaine—Apnoea—Methotrexate—esophageal cancer	0.00255	0.00388	CcSEcCtD
Bupivacaine—Extravasation—Methotrexate—esophageal cancer	0.00248	0.00377	CcSEcCtD
Bupivacaine—Musculoskeletal stiffness—Methotrexate—esophageal cancer	0.00241	0.00367	CcSEcCtD
Bupivacaine—Sweating increased—Cisplatin—esophageal cancer	0.00241	0.00367	CcSEcCtD
Bupivacaine—Bone disorder—Methotrexate—esophageal cancer	0.0024	0.00364	CcSEcCtD
Bupivacaine—Skin discolouration—Methotrexate—esophageal cancer	0.0024	0.00364	CcSEcCtD
Bupivacaine—Vascular purpura—Capecitabine—esophageal cancer	0.00236	0.00359	CcSEcCtD
Bupivacaine—Dysarthria—Methotrexate—esophageal cancer	0.00229	0.00348	CcSEcCtD
Bupivacaine—Respiratory failure—Methotrexate—esophageal cancer	0.0022	0.00335	CcSEcCtD
Bupivacaine—Purpura—Capecitabine—esophageal cancer	0.00219	0.00333	CcSEcCtD
Bupivacaine—Neuropathy peripheral—Cisplatin—esophageal cancer	0.00216	0.00329	CcSEcCtD
Bupivacaine—Lethargy—Capecitabine—esophageal cancer	0.00215	0.00328	CcSEcCtD
Bupivacaine—Diplopia—Capecitabine—esophageal cancer	0.00211	0.00321	CcSEcCtD
Bupivacaine—Osteoarthritis—Capecitabine—esophageal cancer	0.00211	0.00321	CcSEcCtD
Bupivacaine—Depressed level of consciousness—Methotrexate—esophageal cancer	0.00209	0.00318	CcSEcCtD
Bupivacaine—Bradycardia—Cisplatin—esophageal cancer	0.00202	0.00307	CcSEcCtD
Bupivacaine—Cardiac arrest—Capecitabine—esophageal cancer	0.00201	0.00305	CcSEcCtD
Bupivacaine—Urinary retention—Capecitabine—esophageal cancer	0.00201	0.00305	CcSEcCtD
Bupivacaine—Blood creatinine increased—Capecitabine—esophageal cancer	0.00198	0.00301	CcSEcCtD
Bupivacaine—Orthostatic hypotension—Capecitabine—esophageal cancer	0.00193	0.00293	CcSEcCtD
Bupivacaine—Pulmonary oedema—Methotrexate—esophageal cancer	0.00193	0.00293	CcSEcCtD
Bupivacaine—Aspartate aminotransferase increased—Capecitabine—esophageal cancer	0.0019	0.00289	CcSEcCtD
Bupivacaine—Alanine aminotransferase increased—Capecitabine—esophageal cancer	0.00186	0.00283	CcSEcCtD
Bupivacaine—Muscular weakness—Capecitabine—esophageal cancer	0.00186	0.00283	CcSEcCtD
Bupivacaine—Tinnitus—Cisplatin—esophageal cancer	0.00185	0.00281	CcSEcCtD
Bupivacaine—Flushing—Cisplatin—esophageal cancer	0.00184	0.0028	CcSEcCtD
Bupivacaine—Cardiac disorder—Cisplatin—esophageal cancer	0.00184	0.0028	CcSEcCtD
Bupivacaine—Abdominal distension—Capecitabine—esophageal cancer	0.00184	0.00279	CcSEcCtD
Bupivacaine—Dysphagia—Capecitabine—esophageal cancer	0.00182	0.00277	CcSEcCtD
Bupivacaine—Bronchospasm—Capecitabine—esophageal cancer	0.00179	0.00273	CcSEcCtD
Bupivacaine—Sweating increased—Capecitabine—esophageal cancer	0.00178	0.0027	CcSEcCtD
Bupivacaine—Arrhythmia—Cisplatin—esophageal cancer	0.00177	0.00269	CcSEcCtD
Bupivacaine—Erythema—Cisplatin—esophageal cancer	0.00172	0.00262	CcSEcCtD
Bupivacaine—Malnutrition—Cisplatin—esophageal cancer	0.00172	0.00262	CcSEcCtD
Bupivacaine—Flatulence—Cisplatin—esophageal cancer	0.0017	0.00258	CcSEcCtD
Bupivacaine—Muscle spasms—Cisplatin—esophageal cancer	0.00166	0.00252	CcSEcCtD
Bupivacaine—Infestation NOS—Capecitabine—esophageal cancer	0.00163	0.00247	CcSEcCtD
Bupivacaine—Infestation—Capecitabine—esophageal cancer	0.00163	0.00247	CcSEcCtD
Bupivacaine—Vision blurred—Cisplatin—esophageal cancer	0.00162	0.00247	CcSEcCtD
Bupivacaine—Anaphylactoid reaction—Methotrexate—esophageal cancer	0.00162	0.00247	CcSEcCtD
Bupivacaine—Tremor—Cisplatin—esophageal cancer	0.00161	0.00246	CcSEcCtD
Bupivacaine—Lethargy—Methotrexate—esophageal cancer	0.0016	0.00244	CcSEcCtD
Bupivacaine—Neuropathy peripheral—Capecitabine—esophageal cancer	0.00159	0.00242	CcSEcCtD
Bupivacaine—Anaemia—Cisplatin—esophageal cancer	0.00159	0.00242	CcSEcCtD
Bupivacaine—Urinary tract infection—Capecitabine—esophageal cancer	0.00158	0.0024	CcSEcCtD
Bupivacaine—Osteoarthritis—Methotrexate—esophageal cancer	0.00157	0.00239	CcSEcCtD
Bupivacaine—Haematuria—Capecitabine—esophageal cancer	0.00155	0.00236	CcSEcCtD
Bupivacaine—Convulsion—Cisplatin—esophageal cancer	0.00149	0.00227	CcSEcCtD
Bupivacaine—Bradycardia—Capecitabine—esophageal cancer	0.00149	0.00226	CcSEcCtD
Bupivacaine—Lidocaine—ABCB1—esophageal cancer	0.00147	0.143	CrCbGaD
Bupivacaine—Anxiety—Cisplatin—esophageal cancer	0.00146	0.00222	CcSEcCtD
Bupivacaine—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—esophageal cancer	0.00146	0.00222	CcSEcCtD
Bupivacaine—Hypoaesthesia—Capecitabine—esophageal cancer	0.00145	0.00221	CcSEcCtD
Bupivacaine—Oedema peripheral—Capecitabine—esophageal cancer	0.00144	0.00219	CcSEcCtD
Bupivacaine—Anaphylactic shock—Cisplatin—esophageal cancer	0.00141	0.00214	CcSEcCtD
Bupivacaine—Oedema—Cisplatin—esophageal cancer	0.00141	0.00214	CcSEcCtD
Bupivacaine—Infection—Cisplatin—esophageal cancer	0.0014	0.00213	CcSEcCtD
Bupivacaine—Nervous system disorder—Cisplatin—esophageal cancer	0.00138	0.0021	CcSEcCtD
Bupivacaine—Tachycardia—Cisplatin—esophageal cancer	0.00137	0.00209	CcSEcCtD
Bupivacaine—Skin disorder—Cisplatin—esophageal cancer	0.00137	0.00208	CcSEcCtD
Bupivacaine—Tinnitus—Capecitabine—esophageal cancer	0.00136	0.00207	CcSEcCtD
Bupivacaine—Hyperhidrosis—Cisplatin—esophageal cancer	0.00136	0.00207	CcSEcCtD
Bupivacaine—Cardiac disorder—Capecitabine—esophageal cancer	0.00135	0.00206	CcSEcCtD
Bupivacaine—Flushing—Capecitabine—esophageal cancer	0.00135	0.00206	CcSEcCtD
Bupivacaine—Hypotension—Cisplatin—esophageal cancer	0.00131	0.002	CcSEcCtD
Bupivacaine—Chills—Capecitabine—esophageal cancer	0.00131	0.00199	CcSEcCtD
Bupivacaine—Arrhythmia—Capecitabine—esophageal cancer	0.0013	0.00198	CcSEcCtD
Bupivacaine—Musculoskeletal discomfort—Cisplatin—esophageal cancer	0.00128	0.00195	CcSEcCtD
Bupivacaine—Mental disorder—Capecitabine—esophageal cancer	0.00128	0.00195	CcSEcCtD
Bupivacaine—Malnutrition—Capecitabine—esophageal cancer	0.00127	0.00193	CcSEcCtD
Bupivacaine—Erythema—Capecitabine—esophageal cancer	0.00127	0.00193	CcSEcCtD
Bupivacaine—Paraesthesia—Cisplatin—esophageal cancer	0.00126	0.00192	CcSEcCtD
Bupivacaine—Dyspnoea—Cisplatin—esophageal cancer	0.00125	0.00191	CcSEcCtD
Bupivacaine—Flatulence—Capecitabine—esophageal cancer	0.00125	0.0019	CcSEcCtD
Bupivacaine—Back pain—Capecitabine—esophageal cancer	0.00123	0.00187	CcSEcCtD
Bupivacaine—Decreased appetite—Cisplatin—esophageal cancer	0.00122	0.00186	CcSEcCtD
Bupivacaine—Muscle spasms—Capecitabine—esophageal cancer	0.00122	0.00186	CcSEcCtD
Bupivacaine—Gastrointestinal disorder—Cisplatin—esophageal cancer	0.00121	0.00185	CcSEcCtD
Bupivacaine—Infestation NOS—Methotrexate—esophageal cancer	0.00121	0.00184	CcSEcCtD
Bupivacaine—Infestation—Methotrexate—esophageal cancer	0.00121	0.00184	CcSEcCtD
Bupivacaine—Drowsiness—Methotrexate—esophageal cancer	0.00121	0.00184	CcSEcCtD
Bupivacaine—Pain—Cisplatin—esophageal cancer	0.0012	0.00183	CcSEcCtD
Bupivacaine—Vision blurred—Capecitabine—esophageal cancer	0.0012	0.00182	CcSEcCtD
Bupivacaine—Tremor—Capecitabine—esophageal cancer	0.00119	0.00181	CcSEcCtD
Bupivacaine—Anaemia—Capecitabine—esophageal cancer	0.00117	0.00179	CcSEcCtD
Bupivacaine—Sweating—Methotrexate—esophageal cancer	0.00116	0.00177	CcSEcCtD
Bupivacaine—Feeling abnormal—Cisplatin—esophageal cancer	0.00116	0.00176	CcSEcCtD
Bupivacaine—Haematuria—Methotrexate—esophageal cancer	0.00115	0.00176	CcSEcCtD
Bupivacaine—Syncope—Capecitabine—esophageal cancer	0.00114	0.00173	CcSEcCtD
Bupivacaine—Palpitations—Capecitabine—esophageal cancer	0.00112	0.00171	CcSEcCtD
Bupivacaine—Loss of consciousness—Capecitabine—esophageal cancer	0.00112	0.0017	CcSEcCtD
Bupivacaine—Body temperature increased—Cisplatin—esophageal cancer	0.00111	0.00169	CcSEcCtD
Bupivacaine—Cough—Capecitabine—esophageal cancer	0.00111	0.00169	CcSEcCtD
Bupivacaine—Hypertension—Capecitabine—esophageal cancer	0.0011	0.00167	CcSEcCtD
Bupivacaine—Arthralgia—Capecitabine—esophageal cancer	0.00108	0.00165	CcSEcCtD
Bupivacaine—Anxiety—Capecitabine—esophageal cancer	0.00108	0.00164	CcSEcCtD
Bupivacaine—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—esophageal cancer	0.00107	0.00163	CcSEcCtD
Bupivacaine—Confusional state—Capecitabine—esophageal cancer	0.00105	0.00159	CcSEcCtD
Bupivacaine—Oedema—Capecitabine—esophageal cancer	0.00104	0.00158	CcSEcCtD
Bupivacaine—Hypersensitivity—Cisplatin—esophageal cancer	0.00104	0.00158	CcSEcCtD
Bupivacaine—Infection—Capecitabine—esophageal cancer	0.00103	0.00157	CcSEcCtD
Bupivacaine—Shock—Capecitabine—esophageal cancer	0.00102	0.00155	CcSEcCtD
Bupivacaine—Nervous system disorder—Capecitabine—esophageal cancer	0.00102	0.00155	CcSEcCtD
Bupivacaine—Tinnitus—Methotrexate—esophageal cancer	0.00101	0.00154	CcSEcCtD
Bupivacaine—Tachycardia—Capecitabine—esophageal cancer	0.00101	0.00154	CcSEcCtD
Bupivacaine—Asthenia—Cisplatin—esophageal cancer	0.00101	0.00154	CcSEcCtD
Bupivacaine—Cardiac disorder—Methotrexate—esophageal cancer	0.00101	0.00153	CcSEcCtD
Bupivacaine—Skin disorder—Capecitabine—esophageal cancer	0.00101	0.00153	CcSEcCtD
Bupivacaine—Hyperhidrosis—Capecitabine—esophageal cancer	0.001	0.00153	CcSEcCtD
Bupivacaine—Chills—Methotrexate—esophageal cancer	0.000975	0.00148	CcSEcCtD
Bupivacaine—Hypotension—Capecitabine—esophageal cancer	0.000969	0.00147	CcSEcCtD
Bupivacaine—Diarrhoea—Cisplatin—esophageal cancer	0.000962	0.00146	CcSEcCtD
Bupivacaine—Mental disorder—Methotrexate—esophageal cancer	0.000952	0.00145	CcSEcCtD
Bupivacaine—Malnutrition—Methotrexate—esophageal cancer	0.000946	0.00144	CcSEcCtD
Bupivacaine—Erythema—Methotrexate—esophageal cancer	0.000946	0.00144	CcSEcCtD
Bupivacaine—Musculoskeletal discomfort—Capecitabine—esophageal cancer	0.000945	0.00144	CcSEcCtD
Bupivacaine—Insomnia—Capecitabine—esophageal cancer	0.000938	0.00143	CcSEcCtD
Bupivacaine—Paraesthesia—Capecitabine—esophageal cancer	0.000931	0.00142	CcSEcCtD
Bupivacaine—Dyspnoea—Capecitabine—esophageal cancer	0.000924	0.00141	CcSEcCtD
Bupivacaine—Back pain—Methotrexate—esophageal cancer	0.000915	0.00139	CcSEcCtD
Bupivacaine—Dyspepsia—Capecitabine—esophageal cancer	0.000913	0.00139	CcSEcCtD
Bupivacaine—Decreased appetite—Capecitabine—esophageal cancer	0.000901	0.00137	CcSEcCtD
Bupivacaine—Gastrointestinal disorder—Capecitabine—esophageal cancer	0.000895	0.00136	CcSEcCtD
Bupivacaine—Vomiting—Cisplatin—esophageal cancer	0.000894	0.00136	CcSEcCtD
Bupivacaine—Vision blurred—Methotrexate—esophageal cancer	0.000891	0.00136	CcSEcCtD
Bupivacaine—Pain—Capecitabine—esophageal cancer	0.000887	0.00135	CcSEcCtD
Bupivacaine—Constipation—Capecitabine—esophageal cancer	0.000887	0.00135	CcSEcCtD
Bupivacaine—Anaemia—Methotrexate—esophageal cancer	0.000874	0.00133	CcSEcCtD
Bupivacaine—Feeling abnormal—Capecitabine—esophageal cancer	0.000854	0.0013	CcSEcCtD
Bupivacaine—Gastrointestinal pain—Capecitabine—esophageal cancer	0.000848	0.00129	CcSEcCtD
Bupivacaine—Nausea—Cisplatin—esophageal cancer	0.000836	0.00127	CcSEcCtD
Bupivacaine—Cough—Methotrexate—esophageal cancer	0.000825	0.00126	CcSEcCtD
Bupivacaine—Urticaria—Capecitabine—esophageal cancer	0.000824	0.00125	CcSEcCtD
Bupivacaine—Body temperature increased—Capecitabine—esophageal cancer	0.00082	0.00125	CcSEcCtD
Bupivacaine—Abdominal pain—Capecitabine—esophageal cancer	0.00082	0.00125	CcSEcCtD
Bupivacaine—Convulsion—Methotrexate—esophageal cancer	0.000819	0.00125	CcSEcCtD
Bupivacaine—Arthralgia—Methotrexate—esophageal cancer	0.000805	0.00123	CcSEcCtD
Bupivacaine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—esophageal cancer	0.0008	0.00122	CcSEcCtD
Bupivacaine—Confusional state—Methotrexate—esophageal cancer	0.000778	0.00118	CcSEcCtD
Bupivacaine—Anaphylactic shock—Methotrexate—esophageal cancer	0.000772	0.00117	CcSEcCtD
Bupivacaine—Infection—Methotrexate—esophageal cancer	0.000767	0.00117	CcSEcCtD
Bupivacaine—Hypersensitivity—Capecitabine—esophageal cancer	0.000764	0.00116	CcSEcCtD
Bupivacaine—Nervous system disorder—Methotrexate—esophageal cancer	0.000757	0.00115	CcSEcCtD
Bupivacaine—Skin disorder—Methotrexate—esophageal cancer	0.00075	0.00114	CcSEcCtD
Bupivacaine—Hyperhidrosis—Methotrexate—esophageal cancer	0.000746	0.00114	CcSEcCtD
Bupivacaine—Asthenia—Capecitabine—esophageal cancer	0.000744	0.00113	CcSEcCtD
Bupivacaine—Pruritus—Capecitabine—esophageal cancer	0.000734	0.00112	CcSEcCtD
Bupivacaine—Hypotension—Methotrexate—esophageal cancer	0.000721	0.0011	CcSEcCtD
Bupivacaine—Diarrhoea—Capecitabine—esophageal cancer	0.000709	0.00108	CcSEcCtD
Bupivacaine—Musculoskeletal discomfort—Methotrexate—esophageal cancer	0.000703	0.00107	CcSEcCtD
Bupivacaine—Insomnia—Methotrexate—esophageal cancer	0.000698	0.00106	CcSEcCtD
Bupivacaine—Paraesthesia—Methotrexate—esophageal cancer	0.000693	0.00105	CcSEcCtD
Bupivacaine—Dyspnoea—Methotrexate—esophageal cancer	0.000688	0.00105	CcSEcCtD
Bupivacaine—Somnolence—Methotrexate—esophageal cancer	0.000686	0.00104	CcSEcCtD
Bupivacaine—Dizziness—Capecitabine—esophageal cancer	0.000686	0.00104	CcSEcCtD
Bupivacaine—Dyspepsia—Methotrexate—esophageal cancer	0.000679	0.00103	CcSEcCtD
Bupivacaine—Decreased appetite—Methotrexate—esophageal cancer	0.000671	0.00102	CcSEcCtD
Bupivacaine—Gastrointestinal disorder—Methotrexate—esophageal cancer	0.000666	0.00101	CcSEcCtD
Bupivacaine—Pain—Methotrexate—esophageal cancer	0.00066	0.001	CcSEcCtD
Bupivacaine—Vomiting—Capecitabine—esophageal cancer	0.000659	0.001	CcSEcCtD
Bupivacaine—Headache—Capecitabine—esophageal cancer	0.00065	0.000988	CcSEcCtD
Bupivacaine—Feeling abnormal—Methotrexate—esophageal cancer	0.000636	0.000968	CcSEcCtD
Bupivacaine—Gastrointestinal pain—Methotrexate—esophageal cancer	0.000631	0.00096	CcSEcCtD
Bupivacaine—Nausea—Capecitabine—esophageal cancer	0.000616	0.000937	CcSEcCtD
Bupivacaine—Urticaria—Methotrexate—esophageal cancer	0.000613	0.000933	CcSEcCtD
Bupivacaine—Abdominal pain—Methotrexate—esophageal cancer	0.00061	0.000928	CcSEcCtD
Bupivacaine—Body temperature increased—Methotrexate—esophageal cancer	0.00061	0.000928	CcSEcCtD
Bupivacaine—Hypersensitivity—Methotrexate—esophageal cancer	0.000569	0.000865	CcSEcCtD
Bupivacaine—Asthenia—Methotrexate—esophageal cancer	0.000554	0.000843	CcSEcCtD
Bupivacaine—Pruritus—Methotrexate—esophageal cancer	0.000546	0.000831	CcSEcCtD
Bupivacaine—Diarrhoea—Methotrexate—esophageal cancer	0.000528	0.000804	CcSEcCtD
Bupivacaine—Dizziness—Methotrexate—esophageal cancer	0.00051	0.000777	CcSEcCtD
Bupivacaine—Vomiting—Methotrexate—esophageal cancer	0.000491	0.000747	CcSEcCtD
Bupivacaine—Headache—Methotrexate—esophageal cancer	0.000484	0.000736	CcSEcCtD
Bupivacaine—Nausea—Methotrexate—esophageal cancer	0.000458	0.000698	CcSEcCtD
Bupivacaine—PTGER1—Signaling Pathways—CSNK1A1—esophageal cancer	0.000403	0.00121	CbGpPWpGaD
Bupivacaine—SCN10A—Developmental Biology—KDR—esophageal cancer	0.000403	0.00121	CbGpPWpGaD
Bupivacaine—CYP2D6—Biological oxidations—GSTT1—esophageal cancer	0.0004	0.0012	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling by GPCR—ANXA1—esophageal cancer	0.000399	0.0012	CbGpPWpGaD
Bupivacaine—CYP2D6—Biological oxidations—CYP2A6—esophageal cancer	0.000395	0.00119	CbGpPWpGaD
Bupivacaine—SCN10A—Developmental Biology—MET—esophageal cancer	0.000394	0.00119	CbGpPWpGaD
Bupivacaine—SCN4A—Developmental Biology—NOTCH1—esophageal cancer	0.000394	0.00118	CbGpPWpGaD
Bupivacaine—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—esophageal cancer	0.000392	0.00118	CbGpPWpGaD
Bupivacaine—CYP3A4—Biological oxidations—ADH1B—esophageal cancer	0.00039	0.00117	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling by GPCR—SST—esophageal cancer	0.000388	0.00117	CbGpPWpGaD
Bupivacaine—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—esophageal cancer	0.000382	0.00115	CbGpPWpGaD
Bupivacaine—SCN10A—Developmental Biology—NOTCH1—esophageal cancer	0.00038	0.00114	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling by GPCR—GHRL—esophageal cancer	0.000378	0.00114	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—PFN1—esophageal cancer	0.000377	0.00113	CbGpPWpGaD
Bupivacaine—CYP2D6—Biological oxidations—PTGS1—esophageal cancer	0.000374	0.00113	CbGpPWpGaD
Bupivacaine—PTGER1—G alpha (q) signalling events—PIK3CA—esophageal cancer	0.000371	0.00112	CbGpPWpGaD
Bupivacaine—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—esophageal cancer	0.000368	0.00111	CbGpPWpGaD
Bupivacaine—CYP3A4—Biological oxidations—CYP26A1—esophageal cancer	0.000362	0.00109	CbGpPWpGaD
Bupivacaine—CYP3A4—Metapathway biotransformation—CYP26A1—esophageal cancer	0.000357	0.00108	CbGpPWpGaD
Bupivacaine—SCN4A—Developmental Biology—CREBBP—esophageal cancer	0.000357	0.00107	CbGpPWpGaD
Bupivacaine—CYP1A2—Biological oxidations—ALDH2—esophageal cancer	0.000356	0.00107	CbGpPWpGaD
Bupivacaine—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—esophageal cancer	0.000349	0.00105	CbGpPWpGaD
Bupivacaine—CYP2C19—Biological oxidations—CYP1B1—esophageal cancer	0.000346	0.00104	CbGpPWpGaD
Bupivacaine—SCN10A—Developmental Biology—CREBBP—esophageal cancer	0.000344	0.00104	CbGpPWpGaD
Bupivacaine—CYP2C19—Metapathway biotransformation—CYP1B1—esophageal cancer	0.000341	0.00103	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—ELMO1—esophageal cancer	0.000339	0.00102	CbGpPWpGaD
Bupivacaine—CYP1A2—Biological oxidations—GSTT1—esophageal cancer	0.000339	0.00102	CbGpPWpGaD
Bupivacaine—CYP3A4—Biological oxidations—GSTO1—esophageal cancer	0.000337	0.00101	CbGpPWpGaD
Bupivacaine—CYP1A2—Biological oxidations—CYP2A6—esophageal cancer	0.000335	0.00101	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism of lipids and lipoproteins—SLC10A2—esophageal cancer	0.000334	0.001	CbGpPWpGaD
Bupivacaine—CYP3A4—Metapathway biotransformation—GSTO1—esophageal cancer	0.000332	0.001	CbGpPWpGaD
Bupivacaine—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—esophageal cancer	0.000332	0.000997	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—AKAP13—esophageal cancer	0.000331	0.000995	CbGpPWpGaD
Bupivacaine—CYP1A2—Arachidonic acid metabolism—PTGS2—esophageal cancer	0.000327	0.000982	CbGpPWpGaD
Bupivacaine—CYP2C19—Biological oxidations—CYP19A1—esophageal cancer	0.000325	0.000979	CbGpPWpGaD
Bupivacaine—CYP2C19—Metapathway biotransformation—CYP19A1—esophageal cancer	0.000321	0.000965	CbGpPWpGaD
Bupivacaine—CYP2D6—Biological oxidations—CYP1B1—esophageal cancer	0.000318	0.000958	CbGpPWpGaD
Bupivacaine—CYP1A2—Biological oxidations—PTGS1—esophageal cancer	0.000317	0.000954	CbGpPWpGaD
Bupivacaine—CYP2D6—Metapathway biotransformation—CYP1B1—esophageal cancer	0.000314	0.000944	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—HIST1H2BM—esophageal cancer	0.000305	0.000919	CbGpPWpGaD
Bupivacaine—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1A—esophageal cancer	0.000305	0.000918	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—PDE4D—esophageal cancer	0.000303	0.00091	CbGpPWpGaD
Bupivacaine—CYP2D6—Biological oxidations—CYP19A1—esophageal cancer	0.000299	0.0009	CbGpPWpGaD
Bupivacaine—SCN4A—Developmental Biology—ERBB2—esophageal cancer	0.000299	0.000899	CbGpPWpGaD
Bupivacaine—CYP2D6—Metapathway biotransformation—CYP19A1—esophageal cancer	0.000295	0.000888	CbGpPWpGaD
Bupivacaine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—esophageal cancer	0.00029	0.000873	CbGpPWpGaD
Bupivacaine—CYP1A2—Aryl Hydrocarbon Receptor—EP300—esophageal cancer	0.00029	0.000873	CbGpPWpGaD
Bupivacaine—SCN4A—Axon guidance—EGFR—esophageal cancer	0.00029	0.000873	CbGpPWpGaD
Bupivacaine—SCN10A—Developmental Biology—ERBB2—esophageal cancer	0.000288	0.000867	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—GNG7—esophageal cancer	0.000288	0.000866	CbGpPWpGaD
Bupivacaine—SCN10A—Axon guidance—EGFR—esophageal cancer	0.00028	0.000842	CbGpPWpGaD
Bupivacaine—CYP3A4—Biological oxidations—ALDH2—esophageal cancer	0.000275	0.000826	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—XIAP—esophageal cancer	0.00027	0.000811	CbGpPWpGaD
Bupivacaine—CYP1A2—Biological oxidations—CYP1B1—esophageal cancer	0.00027	0.000811	CbGpPWpGaD
Bupivacaine—CYP1A2—Metapathway biotransformation—CYP1B1—esophageal cancer	0.000266	0.0008	CbGpPWpGaD
Bupivacaine—CYP3A4—Biological oxidations—GSTT1—esophageal cancer	0.000261	0.000786	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—SLC10A2—esophageal cancer	0.00026	0.000783	CbGpPWpGaD
Bupivacaine—CYP3A4—Biological oxidations—CYP2A6—esophageal cancer	0.000258	0.000777	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—CTNNA1—esophageal cancer	0.000255	0.000767	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—CXCL2—esophageal cancer	0.000254	0.000763	CbGpPWpGaD
Bupivacaine—CYP1A2—Biological oxidations—CYP19A1—esophageal cancer	0.000254	0.000763	CbGpPWpGaD
Bupivacaine—CYP1A2—Aryl Hydrocarbon Receptor—MYC—esophageal cancer	0.000253	0.000761	CbGpPWpGaD
Bupivacaine—CYP1A2—Metapathway biotransformation—CYP19A1—esophageal cancer	0.00025	0.000752	CbGpPWpGaD
Bupivacaine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—esophageal cancer	0.000248	0.000744	CbGpPWpGaD
Bupivacaine—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—esophageal cancer	0.000248	0.000744	CbGpPWpGaD
Bupivacaine—CYP3A4—Biological oxidations—PTGS1—esophageal cancer	0.000245	0.000736	CbGpPWpGaD
Bupivacaine—SCN4A—Developmental Biology—EP300—esophageal cancer	0.000243	0.000731	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—PSME1—esophageal cancer	0.000237	0.000713	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—PSME2—esophageal cancer	0.000237	0.000713	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—ANXA1—esophageal cancer	0.000236	0.000709	CbGpPWpGaD
Bupivacaine—SCN10A—Developmental Biology—EP300—esophageal cancer	0.000234	0.000705	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—SST—esophageal cancer	0.000229	0.00069	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism of lipids and lipoproteins—ALOX15—esophageal cancer	0.000226	0.000678	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—NOTCH3—esophageal cancer	0.000224	0.000672	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—GHRL—esophageal cancer	0.000224	0.000672	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—FBXW7—esophageal cancer	0.00022	0.000661	CbGpPWpGaD
Bupivacaine—CYP3A4—Biological oxidations—CYP1B1—esophageal cancer	0.000208	0.000626	CbGpPWpGaD
Bupivacaine—SCN4A—Developmental Biology—EGFR—esophageal cancer	0.000207	0.000623	CbGpPWpGaD
Bupivacaine—CYP3A4—Metapathway biotransformation—CYP1B1—esophageal cancer	0.000205	0.000618	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—NOTCH2—esophageal cancer	0.000201	0.000603	CbGpPWpGaD
Bupivacaine—SCN10A—Developmental Biology—EGFR—esophageal cancer	0.0002	0.000601	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism of lipids and lipoproteins—CRABP1—esophageal cancer	0.000197	0.000592	CbGpPWpGaD
Bupivacaine—CYP3A4—Biological oxidations—CYP19A1—esophageal cancer	0.000196	0.000589	CbGpPWpGaD
Bupivacaine—CYP3A4—Metapathway biotransformation—CYP19A1—esophageal cancer	0.000193	0.000581	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—TGFBR2—esophageal cancer	0.000178	0.000535	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—ALOX15—esophageal cancer	0.000176	0.000529	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—BLVRB—esophageal cancer	0.000175	0.000526	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—SLC52A3—esophageal cancer	0.000175	0.000526	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—SMAD4—esophageal cancer	0.000168	0.000506	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—BLVRB—esophageal cancer	0.000161	0.000484	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—SLC52A3—esophageal cancer	0.000161	0.000484	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS1—esophageal cancer	0.000156	0.00047	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—CRABP1—esophageal cancer	0.000153	0.000461	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—SLC10A2—esophageal cancer	0.000149	0.000447	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—CA1—esophageal cancer	0.000149	0.000447	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—HIF1A—esophageal cancer	0.000138	0.000414	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—SLC10A2—esophageal cancer	0.000137	0.000411	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—CA1—esophageal cancer	0.000137	0.000411	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—SLC52A3—esophageal cancer	0.000136	0.00041	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—BLVRB—esophageal cancer	0.000136	0.00041	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—CA2—esophageal cancer	0.000136	0.000409	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	0.000133	0.0004	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—KDR—esophageal cancer	0.000132	0.000396	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—PLCE1—esophageal cancer	0.000126	0.00038	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—ADH7—esophageal cancer	0.000126	0.00038	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—CA2—esophageal cancer	0.000125	0.000376	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	0.000125	0.000376	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—NOTCH1—esophageal cancer	0.000124	0.000373	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS1—esophageal cancer	0.000122	0.000366	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—ADH7—esophageal cancer	0.000116	0.00035	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—PLCE1—esophageal cancer	0.000116	0.00035	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—CA1—esophageal cancer	0.000116	0.000348	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—SLC10A2—esophageal cancer	0.000116	0.000348	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—CREBBP—esophageal cancer	0.000113	0.000338	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—ADH1B—esophageal cancer	0.000111	0.000333	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling by GPCR—EGFR—esophageal cancer	0.000111	0.000333	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—CA2—esophageal cancer	0.000106	0.000319	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—TYMP—esophageal cancer	0.000106	0.000319	CbGpPWpGaD
Bupivacaine—PTGER1—GPCR downstream signaling—PIK3CA—esophageal cancer	0.000106	0.000318	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—SLC52A3—esophageal cancer	0.000105	0.000316	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—BLVRB—esophageal cancer	0.000105	0.000316	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	0.000104	0.000312	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—CYP26A1—esophageal cancer	0.000103	0.00031	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—ADH1B—esophageal cancer	0.000102	0.000307	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—NOS3—esophageal cancer	0.000101	0.000303	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—ALOX15—esophageal cancer	0.0001	0.000302	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—PLCE1—esophageal cancer	9.85e-05	0.000296	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—ADH7—esophageal cancer	9.85e-05	0.000296	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—TYMP—esophageal cancer	9.75e-05	0.000293	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	9.74e-05	0.000293	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling by GPCR—PIK3CA—esophageal cancer	9.6e-05	0.000289	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—GSTO1—esophageal cancer	9.58e-05	0.000288	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—TPI1—esophageal cancer	9.58e-05	0.000288	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—CYP26A1—esophageal cancer	9.48e-05	0.000285	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—ERBB2—esophageal cancer	9.42e-05	0.000283	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—ALOX15—esophageal cancer	9.24e-05	0.000278	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—ALDOB—esophageal cancer	9.19e-05	0.000276	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—SLC10A2—esophageal cancer	8.94e-05	0.000269	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—CA1—esophageal cancer	8.94e-05	0.000269	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—GAPDH—esophageal cancer	8.84e-05	0.000266	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—GSTO1—esophageal cancer	8.81e-05	0.000265	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—TPI1—esophageal cancer	8.81e-05	0.000265	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—CRABP1—esophageal cancer	8.76e-05	0.000264	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—ADH1B—esophageal cancer	8.64e-05	0.00026	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—ALDOB—esophageal cancer	8.45e-05	0.000254	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—GNG7—esophageal cancer	8.34e-05	0.000251	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—CCND1—esophageal cancer	8.33e-05	0.00025	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—TYMP—esophageal cancer	8.26e-05	0.000248	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—CA2—esophageal cancer	8.18e-05	0.000246	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—GAPDH—esophageal cancer	8.13e-05	0.000245	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—CRABP1—esophageal cancer	8.06e-05	0.000242	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—CDKN1A—esophageal cancer	8.05e-05	0.000242	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—CYP26A1—esophageal cancer	8.03e-05	0.000242	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—ALOX15—esophageal cancer	7.83e-05	0.000235	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—ALDH2—esophageal cancer	7.81e-05	0.000235	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—GNG7—esophageal cancer	7.67e-05	0.000231	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—EP300—esophageal cancer	7.66e-05	0.00023	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—ADH7—esophageal cancer	7.6e-05	0.000229	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—PLCE1—esophageal cancer	7.6e-05	0.000229	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—TPI1—esophageal cancer	7.47e-05	0.000225	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—GSTO1—esophageal cancer	7.47e-05	0.000225	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—GSTT1—esophageal cancer	7.43e-05	0.000223	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—CYP2A6—esophageal cancer	7.34e-05	0.000221	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	7.32e-05	0.00022	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—ALDH2—esophageal cancer	7.18e-05	0.000216	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—ALDOB—esophageal cancer	7.16e-05	0.000215	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—ENO1—esophageal cancer	6.96e-05	0.000209	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—PTGS1—esophageal cancer	6.96e-05	0.000209	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—GAPDH—esophageal cancer	6.89e-05	0.000207	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—PSME1—esophageal cancer	6.86e-05	0.000206	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—PSME2—esophageal cancer	6.86e-05	0.000206	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—GSTT1—esophageal cancer	6.83e-05	0.000206	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—CRABP1—esophageal cancer	6.83e-05	0.000205	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—CYP2A6—esophageal cancer	6.76e-05	0.000203	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—MYC—esophageal cancer	6.68e-05	0.000201	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—ADH1B—esophageal cancer	6.67e-05	0.000201	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—EGFR—esophageal cancer	6.53e-05	0.000196	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—GNG7—esophageal cancer	6.5e-05	0.000195	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—PTGS1—esophageal cancer	6.4e-05	0.000193	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—ENO1—esophageal cancer	6.4e-05	0.000193	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—TYMP—esophageal cancer	6.37e-05	0.000192	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—PSME2—esophageal cancer	6.31e-05	0.00019	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—PSME1—esophageal cancer	6.31e-05	0.00019	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—CYP26A1—esophageal cancer	6.2e-05	0.000186	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—ALDH2—esophageal cancer	6.09e-05	0.000183	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—ALOX15—esophageal cancer	6.04e-05	0.000182	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	5.99e-05	0.00018	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—CYP1B1—esophageal cancer	5.92e-05	0.000178	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—GSTT1—esophageal cancer	5.79e-05	0.000174	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—TPI1—esophageal cancer	5.76e-05	0.000173	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—GSTO1—esophageal cancer	5.76e-05	0.000173	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—CYP2A6—esophageal cancer	5.72e-05	0.000172	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	5.7e-05	0.000171	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—PIK3CA—esophageal cancer	5.67e-05	0.000171	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—CYP19A1—esophageal cancer	5.57e-05	0.000167	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—ALDOB—esophageal cancer	5.52e-05	0.000166	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—TP53—esophageal cancer	5.48e-05	0.000165	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—CYP1B1—esophageal cancer	5.45e-05	0.000164	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—PTGS1—esophageal cancer	5.43e-05	0.000163	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—ENO1—esophageal cancer	5.43e-05	0.000163	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—PSME2—esophageal cancer	5.35e-05	0.000161	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—PSME1—esophageal cancer	5.35e-05	0.000161	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—GAPDH—esophageal cancer	5.32e-05	0.00016	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—CRABP1—esophageal cancer	5.27e-05	0.000159	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—CYP19A1—esophageal cancer	5.12e-05	0.000154	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—HMOX1—esophageal cancer	5.08e-05	0.000153	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—GNG7—esophageal cancer	5.01e-05	0.000151	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	4.98e-05	0.00015	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—ABCB1—esophageal cancer	4.88e-05	0.000147	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—ALDH2—esophageal cancer	4.7e-05	0.000141	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—HMOX1—esophageal cancer	4.67e-05	0.000141	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	4.67e-05	0.00014	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—CYP1B1—esophageal cancer	4.61e-05	0.000139	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—ABCB1—esophageal cancer	4.48e-05	0.000135	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—GSTT1—esophageal cancer	4.47e-05	0.000134	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—CYP2A6—esophageal cancer	4.42e-05	0.000133	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—CYP19A1—esophageal cancer	4.34e-05	0.00013	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—PTGS1—esophageal cancer	4.19e-05	0.000126	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—ENO1—esophageal cancer	4.19e-05	0.000126	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—PSME2—esophageal cancer	4.13e-05	0.000124	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—PSME1—esophageal cancer	4.13e-05	0.000124	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—HMOX1—esophageal cancer	3.96e-05	0.000119	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	3.88e-05	0.000117	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—ABCB1—esophageal cancer	3.8e-05	0.000114	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	3.69e-05	0.000111	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—CYP1B1—esophageal cancer	3.56e-05	0.000107	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—CYP19A1—esophageal cancer	3.35e-05	0.000101	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—CREBBP—esophageal cancer	3.26e-05	9.8e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—HMOX1—esophageal cancer	3.05e-05	9.19e-05	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—CREBBP—esophageal cancer	3e-05	9.01e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—ABCB1—esophageal cancer	2.93e-05	8.82e-05	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—NOS3—esophageal cancer	2.92e-05	8.77e-05	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	2.87e-05	8.64e-05	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—NOS3—esophageal cancer	2.68e-05	8.07e-05	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—PTGS2—esophageal cancer	2.67e-05	8.02e-05	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—CREBBP—esophageal cancer	2.54e-05	7.64e-05	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—PTGS2—esophageal cancer	2.45e-05	7.38e-05	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—NOS3—esophageal cancer	2.27e-05	6.84e-05	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—EP300—esophageal cancer	2.22e-05	6.67e-05	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—PTGS2—esophageal cancer	2.08e-05	6.25e-05	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—EP300—esophageal cancer	2.04e-05	6.14e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—CREBBP—esophageal cancer	1.96e-05	5.89e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—NOS3—esophageal cancer	1.75e-05	5.28e-05	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—EP300—esophageal cancer	1.73e-05	5.2e-05	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—PIK3CA—esophageal cancer	1.64e-05	4.94e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—PTGS2—esophageal cancer	1.6e-05	4.83e-05	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—PIK3CA—esophageal cancer	1.51e-05	4.54e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—EP300—esophageal cancer	1.33e-05	4.01e-05	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—PIK3CA—esophageal cancer	1.28e-05	3.85e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—PIK3CA—esophageal cancer	9.87e-06	2.97e-05	CbGpPWpGaD
